SEC Form 4 · accession 0001209191-18-023598
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven J Mento
Director
Period of report
Apr 2, 2018
Accepted (ET)
Apr 4, 2018 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 2, 2018 | M | 10,000 | $7.77 | A | 19,047 | D | |
| Common StockF2 | Apr 2, 2018 | S | 7,115 | $18.3933 | D | 11,932 | D | |
| Common Stock | Apr 2, 2018 | S | 100 | $18.90 | D | 11,832 | D | |
| Common StockF3 | holding | — | — | — | 32,214 | I | By Family Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F4 | $7.77 | Apr 2, 2018 | M | 10,000 | D | — | Jun 11, 2023 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2017.
- F2The price reported is a weighted average price. The shares were sold at prices ranging from $17.85 to $18.85 The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- F3These shares are held in the Mento Family Trust by Steven J. Mento and Linda A. Mento, Trustees of the Mento Family Trust dated December 29, 1994.
- F4Fully vested and exercisable.